|
 |
Pharmaceutical Manufacturing and Packing Sourcer
|
| Christian Puech at Packart discusses how a new tracking and tracing system is helping companies with a need for high-security, high-technology printing to maximise their anti-counterfeiting operations, and ensure safe tracking throughout the pharmaceutical supply chain
Maintaining digital document security through file authentication, file integrity and traceability is a significant challenge for those involved in the pharmaceutical print and packaging sector. Who the owner is, whether it is the original file, genuine, and in the right place are all questions to be considered. Through digital marking, security features can now be painlessly transferred to the ‘analogue’ world using a range of marking and printing technologies. At the same time, the information contained within these markings can remain invisible to the human eye.
There are two key areas that require end-to-end solutions in the pharmaceutical packaging sector:
- Authentication, which entails fighting counterfeiting by ensuring the clear validation of products, containers, packaging and product components
- Tracking and tracing, which manages sales channels by using secure unit traceability by batch, or unique identification by article, in order to trace products anywhere, or at any time, within the supply chain
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Product Development Group, Inc
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented XcelodoseTM powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products...
More info >> |
|
 |
